May 02, 2012, 03.04 PM | Source: Moneycontrol.com
Orchid Chemicals and Pharmaceuticals has got US FDA okay for Naratriptan Tablet, reports CNBC-TV18.
It touched an intraday high of Rs 183.40 and an intraday low of Rs 178.90. At 15:00 hrs the share was quoting at Rs 181.80, up Rs 2.15, or 1.20%.
It was trading with volumes of 124,178 shares. In the previous trading session, the share closed up 1.21% or Rs 2.15 at Rs 179.65.
The company's trailing 12-month (TTM) EPS was at Rs 22.64 per share. (Dec, 2011). The stock's price-to-earnings (P/E) ratio was 8.03. The latest book value of the company is Rs 160.99 per share. At current value, the price-to-book value of the company was 1.13. The dividend yield of the company was 1.65%.
Orchid Pharma surges 14% on USFDA inspection report for TN unit
"Orchid received establishment inspection report (
AP, US govt ink pact to develop Visakhapatnam as 'Smart City'
State Principal Secretary (Municipal Administratio
Lupin confident of growth in US going ahead
"I now the first half of this year has been challe
Facebook India Head Kirthiga Reddy to relocate to US
China isn't the real worry, US economy is, says StanChart
Federal Reserve's next move would be a rate cut go
Sun Pharma to ask FDA in Q1 FY17 for Halol re-inspection
Fischer Chemic: Outcome of board meeting
Fischer Chemic Ltd has informed BSE that the Board